A longtime Pfizer chief's ultra-quiet biotech re-emerges with new cash and plans for the clinic

In August 2018, a tiny biotech spinout from Cornell announced they had hired former high-ranking Pfizer executive Geno Germano as CEO. And then they said nothing else. For two years. Literally, the company, called Elucida Oncology, did not issue a single other press release until this past May, when they hired a chief medical officer.